Evidence map›Paper›PMID 35328776›Full record

ArticleInternational journal of molecular sciences2022

Hepatocyte Proteome Alterations Induced by Individual and Combinations of Common Free Fatty Acids.

Juergen Gindlhuber, Maximilian Schinagl, Laura Liesinger, Barbara Darnhofer, Tamara Tomin, Matthias Schittmayer, Ruth Birner-Gruenberger

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Juergen GindlhuberDiagnostic and Research Institute of Pathology, Medical University of Graz, 8010 Graz, Austria.ORCID 0000-0002-6155-5208
Maximilian SchinaglDiagnostic and Research Institute of Pathology, Medical University of Graz, 8010 Graz, Austria.ORCID 0000-0003-1009-7208
Laura LiesingerDiagnostic and Research Institute of Pathology, Medical University of Graz, 8010 Graz, Austria.
Barbara DarnhoferDiagnostic and Research Institute of Pathology, Medical University of Graz, 8010 Graz, Austria.
Tamara TominInstitute of Chemical Technologies and Analytics, Technische Universität Wien, 1060 Vienna, Austria.ORCID 0000-0002-7071-2316
Matthias SchittmayerInstitute of Chemical Technologies and Analytics, Technische Universität Wien, 1060 Vienna, Austria.ORCID 0000-0003-3249-655X
Ruth Birner-GruenbergerDiagnostic and Research Institute of Pathology, Medical University of Graz, 8010 Graz, Austria.ORCID 0000-0003-3950-0312
TU Wien · ATMedical University of Graz · AT

Funding

Austrian Science Fund FWF KLI 645Austrian Science Fund FWF W 1226
6 · The paper itself

Abstract

Non-alcoholic fatty liver disease is a pathology with a hard-to-detect onset and is estimated to be present in a quarter of the adult human population. To improve our understanding of the development of non-alcoholic fatty liver disease, we treated a human hepatoma cell line model, HepG2, with increasing concentrations of common fatty acids, namely myristic, palmitic and oleic acid. To reproduce more physiologically representative conditions, we also included combinations of these fatty acids and monitored the cellular response with an in-depth proteomics approach and imaging techniques. The two saturated fatty acids initially presented a similar phenotype of a dose-dependent decrease in growth rates and impaired lipid droplet formation. Detailed analysis revealed that the drop in the growth rates was due to delayed cell-cycle progression following myristic acid treatment, whereas palmitic acid led to cellular apoptosis. In contrast, oleic acid, as well as saturated fatty acid mixtures with oleic acid, led to a dose-dependent increase in lipid droplet volume without adverse impacts on cell growth. Comparing the effects of harmful single-fatty-acid treatments and the well-tolerated fatty acid mixes on the cellular proteome, we were able to differentiate between fatty-acid-specific cellular responses and likely common lipotoxic denominators.

Indexed as

Non-alcoholic Fatty Liver DiseaseFatty AcidsFatty Acids, NonesterifiedHepatocytesHumansOleic AcidPalmitic AcidProteomeFatty AcidsFatty Acids, NonesterifiedOleic AcidPalmitic AcidProteomelipotoxicitymyristic acidNAFLDoleic acidpalmitic acid

Identifiers

PMID35328776
PMCPMC8951603
OpenAlexW4220957964

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.